Delivery Order SPE2DB20D2104-SPE2DB24FU96Z

Award Date 7/1/24
Potential Completion Date 7/2/24
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Albuterol HFA 90 MCG inhalers. The contract has a firm-fixed-price of $1,997.88 and a period of performance through November 16, 2023. The award is not designated under any set-aside program. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of albuterol HFA 90 mcg inhalers. The contract is a firm fixed-price Delivery Order with a ceiling value of $2,590.75 and an ultimate completion date of September 19, 2024. The contract has no set-aside designation. As a significant federal contractor, Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,609.68 firm-fixed-price contract is for the delivery of 4,567,104,771 units of the albuterol HFA 90 mcg inhaler with an ultimate completion date of January 31, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,530.22, is for the delivery of Albuterol HFA 90 MCG inhalers. The contract is a Firm Fixed Price Delivery Order with a completion date of May 17, 2024. The award is not associated with a set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Albuterol HFA 90 MCG Inhalers (8.5 GM) to the Defense Logistics Agency (DLA). The $1,031.01 firm-fixed-price delivery order was issued on December 8, 2022, with a completion date of December 9, 2022. This award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for the company to provide...
This is a $3,850.11 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Albuterol HFA 90mcg inhalers. The contract has an ultimate completion date of July 3, 2025 and is not designated as a set-aside. Amerisourcebergen holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,716.39, is for the supply of Albuterol HFA 90 MCG Inhaler 8.5GM, a critical respiratory medication. The contract has a firm fixed-price pricing type and an ultimate completion date of August 13, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical and the Department of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,553.81, is for the delivery of 4,568,076,535 units of albuterol HFA 90 mcg inhalers, 8.5 grams each. The contract is a firm fixed-price, non-set-aside award with a performance period ending on April 30, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Albuterol HFA 90 mcg inhalers. The firm-fixed-price contract has a ceiling value of $1,291.08 and a completion date of August 7, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these critical medical supplies to support military treatment facilities and other federal healthcare programs. The contract is not a set-aside and is part of a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,105.80, is for the delivery of Albuterol HFA 90 MCG inhalers with an ultimate completion date of February 10, 2025. The contract is a firm-fixed-price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is also the holder of a...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB24FU96Z
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of albuterol HFA 90 mcg inhalers. The $1,019.00 firm fixed-price contract has a completion date of July 2, 2024. The award is not associated with a set-aside program. AmerisourceBergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, valued at $999,999,999 and $750,000 respectively, for providing a comprehensive range of pharmaceutical products and medical supplies to support federal healthcare programs, including military treatment facilities and veterans' healthcare.

Generated 2/27/25, 9:46 AM